Medication info
Daplo Tablets 10mg (Dapagliflozin Propanediol Hydrate)

Daplo Tablets 10mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, rhomboid film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202300410 · Approved 2023.01.31 · Insurance code 645907350

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not use this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorder
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used in conjunction with dietary and exercise therapies to assist in blood sugar control for patients with type 2 diabetes. It can be administered alone or in combination with other medications. Notably, for patients with type 2 diabetes whose blood sugar is not adequately controlled and who have cardiovascular disease or risk factors, it is important to refer to an expert's advice regarding the risk of adverse cardiovascular events. This medication is utilized to improve blood sugar control and aid in diabetes management.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not use this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in individuals who are allergic to the active ingredient or excipients, patients with type 1 diabetes, those with diabetic ketoacidosis, individuals with genetic disorders affecting lactose breakdown, and patients undergoing dialysis. It should be used cautiously in patients with low fluid volume or impaired kidney function, and blood pressure and kidney function should be carefully monitored before and after administration. This medication may cause side effects including genital infections, urinary tract infections, hypoglycemia, dehydration symptoms, dizziness, dry mouth, weight loss, and so on, and infections may occur more easily, especially in women or those with a prior history of infection. In severe cases, rare complications such as diabetic ketoacidosis or Fournier's gangrene may occur, so if symptoms like pain, swelling, or redness around the genital area arise, immediate consultation with healthcare professionals is necessary. This medication may increase the risk of hypoglycemia when used in conjunction with drugs that can induce hypoglycemia, such as insulin or sulfonylureas, so dosing adjustments may be required for these medications. Pregnant or breastfeeding women are advised not to use this medication and should discontinue immediately if pregnancy is confirmed. During the use of this medication, the status of fluid volume should be checked periodically, and if symptoms of dehydration or hypotension occur, temporary cessation of administration may be necessary. In case of overdose, there is no specific antidote, so symptomatic treatment should be sought, and appropriate supportive treatment should be received at a hospital if necessary. This medication does not significantly affect the ability to drive or operate machinery, but caution should be observed for symptoms of hypoglycemia when used in combination with other hypoglycemic agents. Finally, this medication should not be used in children as safety and efficacy have not been established.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, elevated hematocrit, initial treatment decrease in renal creatinine clearance, dyslipidemia, initial treatment elevated serum creatinine, increased serum urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, gastroesophageal reflux disease, epigastric pain, diverticulosis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, asthenia, pain, ligament sprain, road traffic accident, drug overdose, ankle fracture, hand fracture, pelvic fracture, meniscal injury, thoracic vertebra fracture, tibial fracture, erythrocytosis, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, headache, nasopharyngitis, upper respiratory infection, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, dry eye, eye pain, retinal disorders, decreased vision, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, glaucoma, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorder, epistaxis, hemoptysis, sputum, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to store it at room temperature between 1°C and 30°C. This helps to maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Yellow, biconvex, rhomboid film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.